Incidensen af seponering på grund af ødemrelaterede bivirkninger var højere for etoricoxib end
The incidence of confirmed congestive heart failure adverse events (events that were serious and resulted in hospitalisation or a visit to an emergency department) was non-significantly higher with etoricoxib than diclofenac 150 mg, and this